Study Description: Subjects who have had a kidney transplant rejection are being asked to allow site to collect two to four blood draws of plasma (4 teaspoons/20 ml). A protein called human leukocyte antigen (HLA) has been identified on the surface of white blood cells that might be associated with longer kidney transplant survival. The HLA proteins are called monomers and Dimers. The purpose of our study is to identify which form of HLA-G (monomer vs. dimer) is associated with longer kidney transplant survival. NOTE: Please be made aware that at this time the Title of this project is being changed from ?Monomer and dimer forms of soluble HLA-G and their inhibitory receptors in Kidney Graft Acceptance? to that which is in Short Title
Principal Investigator: Laura Mulloy
Eligibility Criteria: 1. Subject is between 18 and 70 years of age 2. Subject has to have a living kidney transplant or cadaver kidney transpant 3. Subject must have the ability to sign written informed consent 4. Control group will include subject that have never received an organ transpant or currently pregnant or on any immunosuppressive therapy. 5. Must have had a kidney transplant rejection
Compensation: Yes, subjects will be compensated.
Compensation Explanation: Compensation had now been approved to allocate to newly enrolled subjects, therefore, Informed consent has been revised to indicate same with the amount below. Subjects are to have one initial visit that includes consenting and a blood draw. Each consenting subject who completes the visit will be allocated $35 for that completed visit and if they lives >60 miles one way, subjects will be paid $0.54 per mile along with their stipend of $35.
If you don't see specific studies that interest you, please submit your contact information for future studies.